Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Lambrecht, Maarten" or (type any "bookEditor journalEditor issueEditor" and editor="Lambr...

Add to list
- Journal Article
- A1
- open access
Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Philipp Heumann, Miguel E. Aguado-Barrera, Barbara Avuzzi, David Azria, Erik Briers, Renée Bultijnck (UGent) , Ananya Choudhury, Dirk De Ruysscher, Marie-Pierre Farcy-Jacquet, Valerie Fonteyne (UGent) , et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 178.
Add to list
- Journal Article
- A1
- open access
Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes

Vincent Vakaet (UGent) , Pieter Deseyne, Renée Bultijnck (UGent) , Giselle Post (UGent) , Catharine West, David Azria, Celine Bourgier, Marie-Pierre Farcy-Jacquet, Barry Rosenstein, Sheryl Green, et al.

(2023) ACTA ONCOLOGICA. 62(9). p.1036-1044
Add to list
Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

Stephanie G C Kroeze, Matea Pavic, Karin Stellamans, Yolande Lievens (UGent) , Carlotta Becherini, Marta Scorsetti, Filippo Alongi, Umberto Ricardi, Barbara Alicja Jereczek-Fossa, Paulien Westhoff, et al.

(2023) LANCET ONCOLOGY. 24(3). p.e121-e132
Add to list
- Journal Article
- A1
- open access
Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Harkeran K. Jandu, Colin D. Veal, Laura Fachal, Craig Luccarini, Miguel E. Aguado-Barrera, Manuel Altabas, David Azria, Adinda Baten, Celine Bourgier, Renée Bultijnck (UGent) , et al.

(2023) RADIOTHERAPY AND ONCOLOGY. 187.
Add to list
- Journal Article
- A2
- open access
Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

Elnaz Naderi, Miguel E Aguado-Barrera, Line M H Schack, Leila Dorling, Tim Rattay, Laura Fachal, Holly Summersgill, Laura Martínez-Calvo, Ceilidh Welsh, Tom Dudding, et al.

(2023) JNCI CANCER SPECTRUM. 7(6).
Add to list
ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium

Florian Charlier, Thomas Descamps, Yolande Lievens (UGent) , Xavier Geets, Vincent Remouchamps, Maarten Lambrecht and Luigi Moretti

(2022) RADIOTHERAPY AND ONCOLOGY. 167. p.57-64
Add to list
- Journal Article
- A1
- open access
High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Nuradh Joseph, Alessandro Cicchetti, Alan McWilliam, Adam Webb, Petra Seibold, Claudio Fiorino, Cesare Cozzarini, Liv Veldeman (UGent) , Renée Bultijnck (UGent) , Valerie Fonteyne (UGent) , et al.

(2022) FRONTIERS IN ONCOLOGY. 12.
Add to list
- Journal Article
- A2
- open access
Development and optimization of a machine-learning prediction model for acute desquamation after breast radiation therapy in the multicenter REQUITE cohort

Mahmoud Aldraimli, Sarah Osman, Diana Grishchuck, Samuel Ingram, Robert Lyon, Anil Mistry, Jorge Oliveira, Robert Samuel, Leila E.A. Shelley, Daniele Soria, et al.

(2022) ADVANCES IN RADIATION ONCOLOGY. 7(3).
Add to list
The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Lotte van der Weijst, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Jenny Chang-Claude, Ananya Choudhury, Gilles Defraene, Sylvian Demontois, et al.

(2022) RADIOTHERAPY AND ONCOLOGY. 176. p.127-137
Add to list
- Journal Article
- A1
- open access
Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Lotte van der Weijst, Miguel E. Aguado-Barrera, David Azria, Patrick Berkovic, Pierre Boisselier, Erik Briers, Renée Bultijnck (UGent) , Patricia Calvo-Crespo, Jenny Chang-Claude, Ananya Choudhury, et al.

(2022) LUNG CANCER. 166. p.228-241

Academic Bibliography

Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study

Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data : dosimetry, acute and two years physician and patient-reported outcomes

Metastases-directed stereotactic body radiotherapy in combination with targeted therapy or immunotherapy : systematic review and consensus recommendations by the EORTC–ESTRO OligoCare consortium

Genome-wide association study of treatment-related toxicity two years following radiotherapy for breast cancer

Large-scale meta–genome-wide association study reveals common genetic factors linked to radiation-induced acute toxicities across cancer types

ProCaLung : peer review in stage III, mediastinal node-positive, non-small-cell lung cancer : how to benchmark clinical practice of nodal target volume definition and delineation in Belgium

High weekly integral dose and larger fraction size increase risk of fatigue and worsening of functional outcomes following radiotherapy for localized prostate cancer

Development and optimization of a machine-learning prediction model for acute desquamation after breast radiation therapy in the multicenter REQUITE cohort

The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients : results of the REQUITE study

Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study)

Contents

Support

Contact